MERCURY VACCINES  DAMAGES (English)
Il Thiomersal dei vaccini produce danni anche gravi
Metalli tossici + Amalgami dentali al mercurio
Danni al sistema enzimatico da Vaccini e metalli 
By Giusy Arcidiacono (CT) - arcidiaconogiusy@hotmail.com - Perito Commerciale - chimico
Sindrome della permeabilita' intestinale ed autismo
Metalli tossici dei vaccini = Autismo vedi: PDF -  dott. M. Proietti
Il Thimerosal dei vaccini distrugge e/o altera la flora intestinale essendo una sostanza altamente tossica
Ecco il recente studio che ha coinvolto più di 17.000 bambini fino a 19 anni
Questo studio-indagine attualmente in corso è stato avviato dall’omeopata Andreas Bachmair.
La Verita' sullo studio del dott. Wakefield
Dalle fibre minerali alle nanoparticelle:
.....quali caratteristiche chimico-fisiche determinano la patogenicità delle polveri inalate PDF
Premi in denaro ai medici che vaccinano...
http://www.francoverzella.it/autismo-malattie-croniche/metalli-tossici-e-terapia-chelante-2/
 

Il Thimerosal o thiomersal o mertiolato (sodio etilmercuriotiosalicilato), preservante impiegato nei vaccini e a base di Mercurio organico (quindi una potenziale neuro-immunotossina), provoca reazioni allergiche negli animali e potrebbe aumentare gli effetti collaterali delle vaccinazioni nell'uomo ?
vedi: Thimerosal + Metalli tossici nei vaccini - Bibliografia

Nel 1994 questa ricerca si pronunciava affermativamente:
ABSTRACTS
(1) Int Arch Allergy Immunol 1994 Jul;104(3):296-301
Thimerosal induces toxic reaction in non-sensitized animals. Uchida T, Naito S, Kato H, Hatano I, Harashima A, Terada Y, Ohkawa T, Chino F, Eto K, Department of Safety Research on Biologics, National Institute of Health, Tokyo, Japan.
The effects of injection of thimerosal solution on nonsensitized animals was investigated. Intrafootpad injection of thimerosal solution in nonsensitized mice resulted in a swelling response which peaked 1 h after injection and lasted for more than 24 h. Histopathological examination showed that there were severe edema and infiltration of polymorphonuclear neutrophils at the site of injection. An increased vascular permeability was observed after cutaneous injection of thimerosal solution on the back of nonsensitized rats.
Since mercuric chloride and methyl mercury induced severer reactions, and thiosalicylic acid had no effect, mercury contained in thimerosal would have caused the reactions observed in this study.
These results suggest that part of these hypersensitivity reactions against thimerosal observed among patients were possibly induced by the toxic effect of thimerosal. Therefore, thimerosal contained as a preservative in vaccine may augment the side-effects of the vaccination. PMID: 7518269, UI: 94305382

Tale effetto è stato riscontrato anche nell'uomo ? Si; e questo sin dal lontano 1980.
Già allora venne suggerito che il thimerosal dovesse venire sostituito da qualche altro agente antibatterico (senza mercurio), ma tale suggerimento all'epoca non venne preso in alcuna considerazione:

(2) Contact Dermatitis 1980 Jun;6(4):241-5 Merthiolate hypersensitivity and vaccination.
Forstrom L, Hannuksela M, Kousa M, Lehmuskallio E

Epicutaneous tests with 0.1% merthiolate in petrolatum showed hypersensitivity in 96 of 4647 eczema patients (2.0%) and in seven of 105 healthy recruits (7%). There was a marked preponderance of young age classes in the eczema group. Twelve of 41 merthiolate-positive patients tested reacted to mercury alone, three to thiosalicylic acid alone and one to both. The remaining 25 patients reacted to neither of the individual components although the merthiolate complex as a whole gave a positive test result.

Forty-five of the merthiolate-positive patients were tested subcutaneously with 0.5 ml of a 0.01% merthiolate solution, i.e. a dose equal to that contained in one shot of tetanus toxoid, for example.

Nine patients developed a local reaction at the site of the injection, and the area became eczematous in four cases. In one of the patients the eczema spread over the body, causing fever. Since merthiolate-sensitive patients also react to merthiolate administered intracutaneously, the vaccinator should avoid the use of a needle whose outer surface has been contaminated when the vaccine was aspirated from the bottle. However, even when this precautionary measure is taken, local reactions can be expected in such a high percentage of merthiolate-sensitive persons that merthiolate in vaccines should be replaced by another antibacterial agent.
PMID: 6447032, UI: 80245112

Nel 1984 reazioni allergiche furono riscontrate con i vaccini contro tetano ed encefalite da zecche, e anche allora venne suggerito il possibile ricorso ad alternative al thimerosal nella preparazione di tali vaccini:
(3) Hautarzt 1984 Apr;35(4):192-6

[Reactions to vaccinations against tetanus and tick-borne encephalitis caused by merthiolate].
Lindemayr H, Drobil M, Ebner H

Thirty patients with suspected adverse reactions to tetanus- or tick-borne encephalitis-vaccines were subjected to allergy tests. In 8 of 30 patients epicutaneous and/or intracutaneous tests with merthiolate were positive.

Testing anorganic mercury, formaldehyde, aluminium hydroxide, gentamycin and egg white (i.c. and RAST), no positive reactions were found. After vaccination - prior to testing - merthiolate - positive patients had suffered from local inflammatory reactions at the injection site, fever and lymphadenopathy (four patients), urticarial (three patients) or lichenoid exanthemas (one patient). Reviewing the literature it is suggested that alternatively merthiolate-free vaccines be provided for sensitized individuals.PMID: 6724907, UI: 84211622

Nel 1990 simili reazioni allergiche furono riportate anche per il vaccino contro l'epatite B:

(4) Dermatol Clin 1990 Jan;8(1):161-4
Reactions to thimerosal in hepatitis B vaccines.
Rietschel RL, Adams RM Department of Dermatology, Ochsner Clinic, New Orleans, Louisiana.
Hypersensitivity to thimerosal in vaccines has been reported to induce persistent local reactions, urticarial and generalized exanthematic eruptions, and, in the case of the hepatitis B vaccine, urticaria with asthma. The authors describe two cases of extensive reactions, one in a patient who did not form antibodies to the principal vaccine antigen.
Although not all thimerosal-sensitive patients develop adverse reactions to vaccines containing this material, there is a potential risk, and the reactions can be very long lasting.

PMID: 2137393, UI: 90150805
La sensitizzazione allergica al thimerosal in Austria, che per frequenza è ormai diventata seconda solo all'allergia da nichel, è dovuta alle vaccinazioni ? Una ricerca condotta nel 1991 diede risposta affermativa.

(5) Contact Dermatitis 1991 Jan;24(1):6-10
Vaccination despite thimerosal sensitivity. Aberer W Department of Dermatology I, University of Vienna, Austria.
Thimerosal sensitivity is extremely common in Austria, being surpassed as a contact allergen only by nickel. This high incidence is still rising and is probably due to the frequent vaccinations which are performed in Austria.
Most of the patch-test-positive patients had recently been immunized with thimerosal-containing vaccines, and no other obvious sources of exposure to thimerosal could be found. On retrospective questioning, 48 out of 50 patients had had no problems with their recent immunization; the 2 who reported massive local reactions had received their injections, against the recommendation of the manufacturer, subcutaneously. In a prospective study, 12 thimerosal-sensitized persons received their follow-up immunization at our department, and no side effects occurred. This enables us to conclude that sensitization had occurred through vaccines, but that those amounts of thimerosal delivered i.m. are not sufficient to elicit clinical symptoms. Patch-test positivity to thimerosal thus represents no contra-indication to i.m. immunization with thimerosal-containing vaccines.

PMID: 2044374, UI: 91256734
Nel 1996 in Polonia venne riferita allergia al thimerosal in più del 5% di 685 pazienti sottoposti a vaccinazioni o immunoterapia anti-pollinosi, tutte effettuate con preparazioni contenenti thimerosal. Specialmente il personale sanitario (quasi il 14% di esso) ne risultava affetto:(6) Med Pr 1996;47(2):125-31

[Allergic reaction to merthiolate (a disinfectant) based on material from the Occupational Medicine Institute in Lodz]. Kiec-Swierczynska M. Przychodni Chorob Zawodowych Szpitala Klinicznego, Instytutu Medycyny Pracy, Lodzi.
Incidence and causes of allergy to merthiolate (thimerosal) was studied in 685 patients, examined in the Nofer Institute of Occupational Medicine, during the period from 1 September 1993 to 15 October 1995. Allergy to thimerosal was diagnosed in 39 persons (5.7%) including 25 (6.3%) females and 14 (4.9%) males. Health service workers predominated among those sensitized (13.8% of all medical personnel examined during that period).

In 19 persons only allergy to mercury was observed. Among them 7 showed no skin changes, 6 manifested symptoms of hand dermatitis, in 4 patients atopic dermatitis and in 2 dermatitis diseminata were diagnosed.
Two patients suffered from allergic rhinitis. It was found that the general vaccination of health service workers against viral hepatitis as well as immunotherapy with pollen preparations containing thimerosal (Catalet, Biomed, Poland) were the main causes of allergy to mertiolate.

Allergy to thiosalicyclic acid was not observed and two persons reacted positively to mercuric chloride.

PMID: 8656996, UI: 96252600
Ai primi del 1999, ricercatori italiani hanno riscontrato che il thimerosal induce sensitizzazione allergica in bambini affetti da dermatite atopica (e che quindi è un possibile responsabile dell'insorgenza della stessa).
(7) Contact Dermatitis 1999 Feb;40(2):94-7

Sensitization to thimerosal in atopic children.
Patrizi A, Rizzoli L, Vincenzi C, Trevisi P, Tosti A - Department of Clinical and Experimental Medicine, University of Bologna, Italy.
Thimerosal is an organic mercurial compound widely used as a preservative in vaccines, eyedrops, and contact lens cleaning and storage solutions. 5 infants, 2 female and 3 male, ranging in age from 7 to 28 months and affected by atopic dermatitis (AD) diagnosed according to the Hanifin and Rajka criteria, experienced an exacerbation of their clinical condition 2-10 days after mandatory vaccinations with vaccines containing thimerosal.
Cutaneous lesions of nummular eczema appeared on the trunk, limbs and face.
All patients were patch tested with serial dilutions of thimerosal in petrolatum. A positive patch test reaction to thimerosal 0.1% pet. Was observed in all 5 children. 3 of them also showed a positive reaction at 0. 01% and 0.05% pet. Despite their thimerosal-hypersensitivity, all children completed the entire series of mandatory vaccinations, care being taken to use different needles for injection and aspiration of the vaccine.
The 2-year follow-up did not reveal other episodes of exacerbation of the AD after vaccination.
The present study confirms the high frequency of sensitization to thimerosal in atopic children and suggests that vaccination can cause clinical symptoms in sensitized children.
Nevertheless, sensitization to thimerosal does not prevent children from continuing with mandatory vaccinations.

PMID: 10048654, UI: 99156441
Ma alla fine, sulla base delle innegabili evidenze raggiunte fino ad oggi, e in considerazione del sempre crescente numero di vaccinazioni che vengono fatte ai bambini e purtroppo anche in considerazione ai danni che sono stati resi evidenti, recentemente è stato ufficialmente richiesto da parte dei pediatri e della sanità pubblica americana di eliminare il thimerosal dai vaccini:

(8) MMWR Morb Mortal Wkly Rep 1999 Jul 9;48(26):563-5
Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
The Food and Drug Administration (FDA) Modernization Act of 1997 called for FDA to review and assess the risk of all mercury-containing food and drugs.
In line with this review, U.S. vaccine manufacturers responded to a December 1998 and April 1999 FDA request to provide more detailed information about the thimerosal content of their preparations that include this compound as a preservative. Thimerosal has been used as an additive to biologics and vaccines since the 1930s because it is very effective in killing bacteria used in several vaccines and in preventing bacterial contamination, parti cularly in opened multidose containers. Some but not all of the vaccines recommended routinely for children in the United States contain thimerosal.

PMID: 10418806, UI: 99345147
(9) MMWR Morb Mortal Wkly Rep 1999 Nov 5;48(43):996-8
Recommendations regarding the use of vaccines that contain thimerosal as a preservative.
On October 20, 1999, the Advisory Committee on Immunization Practices (ACIP) reviewed information about thimerosal in vaccines and received updates from CDC's National Immunization Program and several vaccine manufacturers on the current and anticipated availability of vaccines that do not contain thimerosal as a preservative. The review was prompted by a joint statement about thimerosal issued July 8, 1999, by the American Academy of Pediatrics (AAP) and the Public Health Service (PHS) (1) and a comparable statement released by the American Academy of Family Physicians (2).
These statements followed a Congressionally mandated Food and Drug Administration (FDA) review of mercury in drugs and food, which included a reassessment of the use of thimerosal in vaccines.

PMID: 10577494, UI: 20043426 - Link in Internet sull’argomento: http://www.aap.org/new/thimpublic.htm
Thimerosal in Vaccines - an Interim Report to Clinicians
http://www.aap.org/advocacy/releases/jointvacc.htm
Joint Statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (PHS)
http://www.cdc.gov/epo/mmwr/preview/mmwrhtml/mm4843a4.htm
Recommendations Regarding the Use of Vaccines - That Contain Thimerosal as a Preservative

vedi: Bibliografia

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

J Toxicol Environ Health A. 2010;73(10):637-40. doi: 10.1080/15287391003613994."Mercury in vaccines from the Australian childhood immunization program schedule".
By Austin DW1, Shandley KA, Palombo EA. - Author information
Abstract
Nonostante l'eliminazione del mercurio (Hg) -based thimerosal conservante dai vaccini presenti nel prospetto australiano del Programma per i bambini di Vaccinazione, permangono preoccupazioni tra alcuni ricercatori e genitori per la sicurezza del presente programma, in parte a causa di una paura di tracce residue di Hg.
Lo scopo di questo studio era di valutare in modo indipendente vaccini per l'infanzia per la presenza di Hg. Otto vaccini somministrati ai bambini sotto l'età di 5 anni sono stati valutati per il contenuto Hg attraverso un analizzatore di mercurio diretta DMA-80.
Sette dei vaccini 8 conteneva livelli rilevabili di Hg (meno di 1 ppb); tuttavia, 1 vaccino (Infanrix hexa) sono risultati positivi per Hg a 10 ppb. Il risultato è stato confermato e validato da ripetere le prove del campione originale. Test di follow-up è stato condotto su tre campioni supplementari di Infanrix hexa (uno dallo stesso lotto di produzione e due da molto diverso). Tutti e tre sono risultati positivi per Hg (media di 9,7 ppb).
Sebbene i livelli di Hg rilevati sono sostanzialmente inferiori rispetto a qualsiasi limite di sicurezza di esposizione stabiliti, i risultati di questo studio rivelano che esistono inesattezze nei messaggi pubblici della salute, comunicazioni professionali e documentazione ufficiali per quanto riguarda il contenuto di Hg in almeno un vaccino infanzia.
Nell'interesse della salute pubblica, spetta a produttori di vaccini e le agenzie responsabili, come la Therapeutic Goods Administration e il Dipartimento federale della Sanità e invecchiamento di affrontare la questione come una questione di urgenza.
PMID: 20391108 [PubMed - indexed for MEDLINE]

Commento NdR: come potete osservare, malgrado la "buona volonta" all'indagine, NON si effettuano delle ricerche serie per trovare TUTTE le sostanze tossico-nocive dei vaccini !
...infatti NON si sono cercate tutte le sostanze tossiche vaccinali, ma solo il mercurio e suoi derivati, inoltre le analisi di laboratorio NON hanno previsto la ricerca delle nanoparticelle dei metalli tossici, SEMPRE PRESENTI in TUTTI i Vaccini.... e' evidente che sono tutte ricerche "pilotate" !